학술논문
Obicetrapib on top of maximally tolerated lipid-modifying therapies in participants with or at high risk for atherosclerotic cardiovascular disease: rationale and designs of BROADWAY and BROOKLYN
Document Type
Article
Author
Nicholls, S.J.; Nelson, A.J.; Ditmarsch, M.; Kastelein, J.J.P.; Curcio, D.; Wuerdeman, E.; Neild, A.; Kling, D.; Hsieh; Davidson, M.H.; Ballantyne, C.M.; Ray, K.K.; Navar, A.M.; Nissen, S.E.; Golberg, A.C.; Brunham, L.R.; Dicklin, M.R.; Ference, B.A.; Laufs, U.; Banach, M.; Mehran, R.; Catapano, A.L.
Source
In: American Heart Journal . (American Heart Journal, August 2024, 274:32-45)
Subject
Language
English
ISSN
10976744
00028703
00028703